Menu

Experience

Brian Leaf

    • Super Group Completes Warrant Exchange Offer and Consent Solicitation 


    • MaxCyte – $202 Million IPO 


    • Elevation Oncology – $107 Million IPO 


    • IronNet Agrees to SPAC Merger With LGL Systems Acquisition Corporation 


    • AvePoint to Combine With Apex Technology, a Special Purpose Acquisition Company, at $2 Billion Value 


    • NexImmune – $127 Million IPO 


    • Sensei Biotherapeutics – $133 Million IPO 


    • Oncorus – $98 Million IPO 


    • Taysha Gene Therapies – $181 Million IPO 


    • VIA optronics – $94 Million IPO 


    • Dyne Therapeutics – $268 Million IPO 


    • Silence Therapeutics – Direct Listing  


    • Passage Bio - $216 Million IPO 


    • Genfit - $155 Million IPO 


    • Entasis Therapeutics – $75 Million IPO 


    • Autolus – $173 Million IPO 


    • Sucampo Sells to Mallinckrodt for $1.2 Billion 


    • ERYTECH – $144 Million IPO 


    • Cooley Advises on Nightstar + NuCana IPOs 


    • ERYTECH Closes €70.5 Million Private Placement to US + European Investors 


    • Recro Pharma – $15 Million Follow-On  


    • Invotas Sells to FireEye 


    • Cooley Advises ERYTECH on €25.4 Million Private Placement 


    • ERYTECH Private Placement 


    • Aclaris Therapeutics IPO 


    • Axovant Completes $362 Million IPO 


    • DBV Technologies Completes Concurrent Public Offerings 


    • T2 Biosystems IPO 


    • 2U $119 Million Initial Public Offering 


    • Egalet Corporation IPO 


    • Eleven Biotherapeutics IPO 


    • First US IPO of 2014 for GlycoMimetics 


    • TetraLogic Initial Public Offering 


    • Millennial Media Acquisition of Jumptap 


    • Onconova Therapeutics IPO 


    • OnCore Biopharma Announces Merger Agreement with Tekmira Pharmaceuticals 


    • Tenable – $288 Million IPO 


    • Merus IPO – $61 Million